openPR Logo
Press release

Maximizing ROI of Pharma Competitive Intelligence

07-15-2020 10:16 AM CET | Health & Medicine

Press release from: BiopharmaVantage

/ PR Agency: BiopharmaVantage

Maximizing ROI of pharmaceutical competitive intelligence engagements is vital for a variety of reasons. BiopharmaVantage, the specialist pharma competitive intelligence firm describes the key success factors that users need to focus on in order to maximize the ROI of engagements. The firm recommends the usage of the following multi-factor framework:

Aren’t they well known?
Collectors become defenders
Consulting firm aspirants
Procuring non-core services of suppliers
Learn from the evolving market
An agency with ex-pharma employees
Intelligence collection is the bulk of the work
Asset-focused executives
Rigid buying process

About BiopharmaVantage

BiopharmaVantage is a specialist firm that specializes in providing premium quality competitive intelligence services to pharmaceutical and biotechnology companies. If you would like to discuss how we can assist you, then please contact us.

 

Contact:

Katherine Mae

Business Development Manager

BiopharmaVantage, Oxford, UK

Email: enquiries@biopharmavantage.com

Website: www.biopharmavantage.com

 

BiopharmaVantage, Oxford, UK

BiopharmaVantage is a specialist firm that specializes in providing premium quality competitive intelligence services to pharmaceutical and biotechnology companies. If you would like to discuss how we can assist you, then please contact us.

 

Contact:

Katherine Mae

Business Development Manager

BiopharmaVantage, Oxford, UK

Email: enquiries@biopharmavantage.com

Website: www.biopharmavantage.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Maximizing ROI of Pharma Competitive Intelligence here

News-ID: 2090004 • Views: 278

More Releases for Oxford

Oxford Shoes Market Is Booming Worldwide | Alden, Carmina, Sutor, Skechers
HTF MI recently introduced Global Oxford Shoes Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are G&G, Edward Green, John Lobb Bootmaker, BALLY, Alden, Carmina, Sutor, Skechers,
NHS Dentist Oxford – Damira Dental
Damira Dental Bury Knowle is an excellent NHS Dentist in Oxford dedicated to providing exceptional levels of NHS dental care. Established in 2003, Damira Dental Studios has grown from this one small practice in Oxford to a leading provider of high quality dentistry across Southern England. Damira Dental now comprises 18 practices across London, Hampshire and Oxfordshire! They offer a comprehensive range of treatments both through the NHS and privately
Oxford Instruments awarded Best Technology Company 2012
Oxford Instruments plc, a leading provider of high technology tools and systems for research and industry, has won the award for Best Technology Company 2012 at the annual PLC Awards. The awards, sponsored by Price Waterhouse Coopers, reward excellence amongst the smaller companies quoted on the London Stock Exchange. Attracting more than 1,500 guests, including quoted companies, investment banks, fund managers, investment analysts and corporate advisors, the awards are 'the' City
Oxford Gene Technology and Abcodia form Partnership
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a collaborative agreement with Abcodia, a specialist company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases, aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from
Oxford Instruments plc enters the FTSE 250
The FTSE Group has announced that Oxford Instruments plc, the leading provider of high technology tools and systems for industry and research, has been promoted to the FTSE 250 index. Jonathan Flint, Chief Executive, says “Joining the FTSE 250 is an outstanding milestone for Oxford Instruments and something all our employees can be extremely proud of. It reflects the huge steps forward the Group has made during recent times, successfully
Oxford Gene Technology releases new white paper
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has released a new white paper discussing the relative merits of DNA microarrays and next generation sequencing (NGS) for human genome analysis. Although the development of genome analysis technologies such as DNA microarrays and NGS has provided the researcher with the unique ability to screen for sequence variants of clinical relevance, each technology has